Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States-Author's Reply
Aliment Pharmacol Ther
.
2025 Jan 23.
doi: 10.1111/apt.18511.
Online ahead of print.
Authors
Pojsakorn Danpanichkul
1
,
Donghee Kim
2
,
Chun Wei Pan
3
,
Amit G Singal
4
,
Ju Dong Yang
5
6
,
Karn Wijarnpreecha
7
8
9
Affiliations
1
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
2
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
3
Department of Medicine, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA.
4
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
5
Karsh Division of Gastroenterology and Hepatology, Comprehensive Transplant Center, California, Los Angeles, USA.
6
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, California, Los Angeles, USA.
7
Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA.
8
Department of Internal Medicine, Banner University Medical Center, Phoenix, Arizona, USA.
9
BIO5 Institute, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
PMID:
39846176
DOI:
10.1111/apt.18511
No abstract available
Keywords:
alcohol; epidemiology; hepatocellular carcinoma; metabolic syndrome; oncology.
Publication types
Editorial